NXGL NEXGEL INC

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Webull Consumer Virtual Webinar on February 18, 2025.

Webull Consumer Virtual Webinar Details:

Presentation: Tuesday, February 18th at 2:40 p.m. ET

Webcast:

To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at Webull or email KCSA Strategic Communications at .

About NEXGEL, Inc.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254



EN
13/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEXGEL INC

 PRESS RELEASE

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring I...

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025 LANGHORNE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 on March 25 and 26, 2025. iAccess Alpha Virtual Conference Detail...

 PRESS RELEASE

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 1...

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025 LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Webull Consumer Virtual Webinar on February 18, 2025. Webull Consumer Virtual Webinar Details:Presentation: Tuesday, February 18th at 2:40 p.m. ETWebcast: To schedule ...

 PRESS RELEASE

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 an...

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025 Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management expects to generate at least $13 million in revenue for 2025 and to achieve positive cash flow from operations during the year LANGHORNE, Pa., Jan. 22, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) produ...

 PRESS RELEASE

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced the appointment of Joseph F. McGuire as Chief Financial Officer, effective January 1, 2025. Adam E. Drapczuk III, current Chief Financial Officer, will remain with the Company as a consultant. Adam Levy, Chief Executive Officer, stated, “As our bu...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 7, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch